These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy. Minami Y, Kajimoto K, Kawana M, Hagiwara N, Sherrid MV. Int J Cardiol; 2010 May 28; 141(2):195-7. PubMed ID: 19097655 [Abstract] [Full Text] [Related]
7. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. Sherrid MV, Barac I, McKenna WJ, Elliott PM, Dickie S, Chojnowska L, Casey S, Maron BJ. J Am Coll Cardiol; 2005 Apr 19; 45(8):1251-8. PubMed ID: 15837258 [Abstract] [Full Text] [Related]
8. Disopyramide for Hypertrophic Cardiomyopathy: A Pragmatic Reappraisal of an Old Drug. Verlinden NJ, Coons JC. Pharmacotherapy; 2015 Dec 19; 35(12):1164-72. PubMed ID: 26684556 [Abstract] [Full Text] [Related]
11. Markers of responsiveness to disopyramide in patients with hypertrophic cardiomyopathy. Habib M, Hoss S, Bruchal-Garbicz B, Chan RH, Rakowski H, Williams L, Adler A. Int J Cardiol; 2019 Dec 15; 297():75-82. PubMed ID: 31615649 [Abstract] [Full Text] [Related]
12. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy. Ruzyłło W, Chojnowska L, Demkow M, Witkowski A, Kuśmierczyk-Droszcz B, Piotrowski W, Rausinska L, Karcz M, Małecka L, Rydlewska-Sadowska W. Eur Heart J; 2000 May 15; 21(9):770-7. PubMed ID: 10739733 [Abstract] [Full Text] [Related]
17. Disopyramide is a safe and effective treatment for children with obstructive hypertrophic cardiomyopathy. Topriceanu CC, Field E, Boleti O, Cervi E, Kaski JP, Norrish G. Int J Cardiol; 2023 Jan 15; 371():523-525. PubMed ID: 36174821 [Abstract] [Full Text] [Related]
18. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy. Kimball BP, Bui S, Wigle ED. Am Heart J; 1993 Jun 15; 125(6):1691-7. PubMed ID: 8498312 [Abstract] [Full Text] [Related]
19. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Chang SM, Lakkis NM, Franklin J, Spencer WH, Nagueh SF. Circulation; 2004 Feb 24; 109(7):824-7. PubMed ID: 14967729 [Abstract] [Full Text] [Related]
20. Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging. Kwon DH, Smedira NG, Popovic ZB, Lytle BW, Setser RM, Thamilarasan M, Schoenhagen P, Flamm SD, Lever HM, Desai MY. Heart; 2009 Nov 24; 95(21):1784-91. PubMed ID: 19549621 [Abstract] [Full Text] [Related] Page: [Next] [New Search]